Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Karim Bendjelid
2020 Critical Care  
doi:10.1186/s13054-020-03144-6 pmid:32646518 fatcat:eq222hazbba37l6pa46jx6uevq